Gambaran Kadar Hemoglobin, Trombosit, dan Rasio Neutrofil Limfosit pada Pasien Kanker Kolorektal di Rumah Sakit Umum Pusat Haji Adam Malik Medan

Abstract

Background. Colorectal cancer is one of the global health issue, with approximately 1.9 million new cases and 930,000 deaths reported and are predicted to continue to increase. Hemoglobin, platelets, and neutrophil-lymphocyte ratio are important laboratory tests for colorectal cancer. The cancer stage progression may show different laboratory findings.Objective. To know the overview of laboratory results among colorectal cancer patients at H. Adam Malik Medan General Hospital from January 2023 to June 2024. Methods. This study used descriptive observational method with cross sectional approach and used secondary data from medical records. The study sample consisted of 141 patients who were taken through the total sampling method. Data analysis was performed using descriptive statistics. Results and Discussion. Most patients diagnosed with colorectal cancer were aged 46-55 years (34%), male (50.4%), and had comorbidities (72.3%). Stage II was the most common stage found at 51.8%. Based on hemoglobin level, the majority of patients were anemia (83%) with the distribution of patients increasing at higher stages. Platelet count of the majority of patients were within the normal range (80%) with the frequency distribution of patients decreasing at higher stages. In terms of neutrophil-lymphocyte ratio, the majority of patients were elevated (78%) with the distribution of patients increasing at higher stages. Conclusion. The overview of colorectal cancer patients at H. Adam Malik Medan General Hospital from January 2023 to June 2024 were decreased hemoglobin level, normal platelet count, and increased neutrophil-lymphocyte ratio.